{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:07:30Z","timestamp":1794071250220,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ijantimicag.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T08:42:30Z","timestamp":1368002550000},"page":"S17-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"S1","title":["Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA)"],"prefix":"10.1016","volume":"42","author":[{"given":"I.M.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0005","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijantimicag.2012.06.019","article-title":"Correlation between oritavancin and vancomycin minimum inhibitory concentrations in staphylococci","volume":"40","author":"Arhin","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance","volume":"39","author":"Gould","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/JCM.05520-11","article-title":"Is vancomycin MIC \u2018creep\u2019 method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010","volume":"50","author":"Edwards","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"e29573","DOI":"10.1371\/journal.pone.0029573","article-title":"Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains","volume":"7","author":"Cafiso","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0030","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/JCM.01158-12","article-title":"Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus","volume":"50","author":"Ludwig","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0040","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.05609-11","article-title":"Vancomycin AUC24\/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization","volume":"56","author":"Brown","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0045","series-title":"51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"More aggressive vancomycin (VAN) pharmacodynamic (PD) targets predict survival for methicillin-resistant Staphylococcus aureus (MRSA) septic shock","author":"Zelenitsky","year":"2011"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/infdis\/jir275","article-title":"Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?","volume":"204","author":"Holland","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MD.0b013e3181f1851e","article-title":"Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S. aureus bacteremia","volume":"89","author":"Chen","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0060","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2008.05.007","article-title":"Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections","volume":"32","author":"Hsu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0070","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can\u2019t get there from here","volume":"52","author":"Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"26","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0080","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/jac\/dks131","article-title":"Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus","volume":"67","author":"Park","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/jac\/dkq340","article-title":"Rapid detection of vancomycin-non-susceptible Staphylococcus aureus using the spiral gradient endpoint technique","volume":"65","author":"Doddangoudar","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systemic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/JCM.06208-11","article-title":"Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in North India","volume":"50","author":"Banerjee","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/cid\/cis492","article-title":"In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates","volume":"55","author":"Saravolatz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/jac\/dkq179","article-title":"Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"65","author":"Goldberg","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijantimicag.2011.03.006","article-title":"Daptomycin evaluation of a high-dose treatment strategy","volume":"38","author":"Wu","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case\u2013control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0125","series-title":"52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Comparison of high dose daptomycin (DAP) and dose optimized vancomycin (VAN) for MRSA bacteremia and infective endocarditis (IE)","author":"Davis","year":"2012"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0130","first-page":"582","article-title":"Daptomycin (DAP) versus vancomycin (VAN) for methicillin-resistant Staphylococcus aureus isolates","volume":"55","author":"Muray","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0135","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkp346","article-title":"Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies","volume":"64","author":"Steenbergen","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0140","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/JCM.00880-10","article-title":"First report of staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization","volume":"48","author":"Mendes","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2007.09.009","article-title":"Linezolid pharmacokinetic\/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion","volume":"31","author":"Adembri","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/infdis\/jir848","article-title":"Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection","volume":"205","author":"Gould","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"e000797","DOI":"10.1136\/bmjopen-2011-000797","article-title":"Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006\u20132010: retrospective cohort study and time-series intervention analysis","volume":"2","author":"Lawes","year":"2012","journal-title":"BMJ Open"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T04:53:36Z","timestamp":1539665616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":31,"alternative-id":["S0924857913001325"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.04.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}